Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
June 12th, 2023 |
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities - Implementation Sites |
Health Resources and Services Administration |
July 1st, 2023 |
Preventive Health and Health Services Block Grant- 2023 CDC-RFA-TO23-2304 |
CENTERS FOR DISEASE CONTROL CSTLTS |
May 7th, 2026 |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) |
National Institutes of Health |
May 12th, 2023 |
PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States (EHE) Component C mpox Supplement |
Centers for Disease Control NCHHSTP |
December 1st, 2023 |
Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01) |
Centers for Disease Control and Prevention ERA |
July 11th, 2023 |
Closing the Gap with Social Determinants of Health Accelerator Plans |
Centers for Disease Control NCCDPHP |
September 25th, 2023 |
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2025 |
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2023 |
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2026 |
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) |
National Institutes of Health |
May 7th, 2026 |
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
May 24th, 2023 |
Lowlands Health Activity |
Ethiopia USAID Addis Ababa |
July 24th, 2023 |
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 24th, 2023 |
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2026 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2026 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
May 15th, 2025 |
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 10th, 2023 |
Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
August 25th, 2023 |
Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 15th, 2023 |
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) |
National Institutes of Health |
|
September 12th, 2023 |
Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed) |
National Institutes of Health |
April 27th, 2023 |
Community Health Equity through Systems Strengthening (CHESS) |
Ghana USAID Accra |
January 17th, 2025 |
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2023 |
Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Centers for Disease Control and Prevention ERA |
May 1st, 2023 |
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2026 |
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 15th, 2023 |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional) |
National Institutes of Health |
June 5th, 2025 |
Strategic Prevention Framework - Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations |
Substance Abuse and Mental Health Services Adminis |
June 5th, 2025 |
Strategic Prevention Framework - Partnerships for Success for States |
Substance Abuse and Mental Health Services Adminis |
June 15th, 2023 |
Strategies for Responsibly Reporting Back Environmental Health and Non-Genomic Research Results (R01 Clinical Trial Optional) |
National Institutes of Health |
June 6th, 2025 |
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 13th, 2023 |
Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18) |
Agency for Health Care Research and Quality |
October 18th, 2023 |
Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
September 19th, 2025 |
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
July 14th, 2023 |
BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional) |
National Institutes of Health |
August 11th, 2025 |
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
National Institutes of Health |
June 2nd, 2023 |
Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional) |
National Institutes of Health |
June 19th, 2023 |
Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2026 |
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2026 |
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) |
National Institutes of Health |